Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancerKEUN SEOK LEE; IN HAE PARK; NAM, Byung-Ho et al.Investigational new drugs. 2013, Vol 31, Num 1, pp 152-159, issn 0167-6997, 8 p.Article

Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissueIN HAE PARK; YOUNGMEE KWON; RO, Jae Y et al.Breast cancer research and treatment. 2010, Vol 123, Num 1, pp 125-128, issn 0167-6806, 4 p.Article

Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancerLIM, Hyeong-Seok; HAN JU LEE; KEUN SEOK LEE et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3837-3845, issn 0732-183X, 9 p.Article

Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatmentIN HAE PARK; RO, Jungsil; PARK, Sohee et al.Breast cancer research and treatment. 2012, Vol 131, Num 2, pp 455-461, issn 0167-6806, 7 p.Article

Health-Related Quality of Life in Survivors With Breast Cancer 1 Year After Diagnosis Compared With the General Population: A Prospective Cohort StudyEUN SOOK LEE; MYUNG KYUNG LEE; SOO HYUN KIM et al.Annals of surgery. 2011, Vol 253, Num 1, pp 101-108, issn 0003-4932, 8 p.Article

Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancerKONG, Sun-Young; NAM, Byung-Ho; KEUN SEOK LEE et al.Clinical chemistry (Baltimore, Md.). 2006, Vol 52, Num 8, pp 1510-1515, issn 0009-9147, 6 p.Article

Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissuesSUN JUNG KIM; KANG, Han-Sung; JUNG, So-Youn et al.Journal of molecular medicine (Berlin. Print). 2010, Vol 88, Num 11, pp 1123-1131, issn 0946-2716, 9 p.Article

Phase II Parallel Group Study Showing Comparable Efficacy Between Premenopausal Metastatic Breast Cancer Patients Treated With Letrozole Plus Goserelin and Postmenopausal Patients Treated With Letrozole Alone As First-Line Hormone TherapyIN HAE PARK; RO, Jungsil; KEUN SEOK LEE et al.Journal of clinical oncology. 2010, Vol 28, Num 16, pp 2705-2711, issn 0732-183X, 7 p.Article

The attitudes of cancer patients and their families toward the disclosure of terminal illnessYOUNG HO YUN; CHANG GEOL LEE; KIM, Si-Young et al.Journal of clinical oncology. 2004, Vol 22, Num 2, pp 307-314, issn 0732-183X, 8 p.Article

Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancerJOO YOUNG JUNG; JUNG HYE KWON; PARK, Young-Iee et al.Oncology reports. 2009, Vol 21, Num 2, pp 523-529, issn 1021-335X, 7 p.Article

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancerKEUN SEOK LEE; HYUN CHEOL CHUNG; SEOCK AH IM et al.Breast cancer research and treatment. 2008, Vol 108, Num 2, pp 241-250, issn 0167-6806, 10 p.Article

Validation study of the Korean version of the brief fatigue inventoryYOUNG HO YUN; XIN SHELLEY WANG; JUNG SUK LEE et al.Journal of pain and symptom management. 2005, Vol 29, Num 2, pp 165-172, issn 0885-3924, 8 p.Article

Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancerIN HAE PARK; LEE, Yeon-Su; KEUN SEOK LEE et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 5, pp 1263-1271, issn 0344-5704, 9 p.Article

Epidermal Growth Factor Receptor Expression Discrepancies in Metastatic Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan-Based Chemotherapy Refractory to Irinotecan and Oxaliplatin. CommentaryHAN, Hye-Suk; HEE JIN CHANG; YONG SANG HONG et al.Diseases of the colon & rectum. 2009, Vol 52, Num 6, pp 1144-1153, issn 0012-3706, 10 p.Article

Metaplastic breast cancer: clinicopathological features and its prognosisLEE, Hyewon; JUG, So-Youn; KYOUNG LAN KO et al.Journal of clinical pathology. 2012, Vol 65, Num 5, pp 441-446, issn 0021-9746, 6 p.Article

Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancerHAN, Hye-Suk; RO, Jungsil; KEUN SEOK LEE et al.Breast cancer research and treatment. 2009, Vol 115, Num 2, pp 335-342, issn 0167-6806, 8 p.Article

Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancerSUN JUNG KIM; KANG, Han-Sung; HYE LIM CHANG et al.Oncology reports. 2008, Vol 19, Num 3, pp 663-668, issn 1021-335X, 6 p.Article

PREOPERATIVE CHEMORADIATION WITH CETUXIMAB, IRINOTECAN, AND CAPECITABINE IN PATIENTS WITH LOCALLY ADVANCED RESECTABLE RECTAL CANCER: A MULTICENTER PHASE II STUDYSUN YOUNG KIM; YONG SANG HONG; LIM, Seok-Byung et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 3, pp 677-683, issn 0360-3016, 7 p.Article

Use of a Decision Aid to Help Caregivers Discuss Terminal Disease Status With a Family Member With Cancer: A Randomized Controlled TrialYOUNG HO YUN; MYUNG KYUNG LEE; OH, Ho-Suk et al.Journal of clinical oncology. 2011, Vol 29, Num 36, pp 4811-4819, issn 0732-183X, 9 p.Article

Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02YEON HEE PARK; KYUNG HAE JUNG; LEE, Soohyeon et al.Journal of clinical oncology. 2013, Vol 31, Num 14, pp 1732-1739, issn 0732-183X, 8 p.Article

High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancerRHEE, Jiyoung; HAN, Sae-Won; IN HAE PARK et al.Breast cancer research and treatment. 2011, Vol 125, Num 1, pp 107-114, issn 0167-6806, 8 p.Article

Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancerJUNG, So-Youn; HYUN YUL KIM; KEUN SEOK LEE et al.Breast cancer research and treatment. 2010, Vol 120, Num 3, pp 627-637, issn 0167-6806, 11 p.Article

A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancerJUNG HAN KIM; DONG HUN LEE; YOUNG LEE PARK et al.Lung cancer. 2006, Vol 54, Num 1, pp 57-62, issn 0169-5002, 6 p.Article

Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/ III breast cancer: The Korean Cancer Study Group BR 07-01IM, Seock-Ah; KEUN SEOK LEE; NOH, Dong-Young et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 589-600, issn 0167-6806, 12 p.Article

A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancerKEUN SEOK LEE; RO, Jungsil; KYUNG HWAN SHIN et al.Breast cancer research and treatment. 2008, Vol 109, Num 3, pp 481-489, issn 0167-6806, 9 p.Article